The U.S. Supreme Court recieved an amicus brief on FDA regulation.

Determining the relative costs and benefits of federal regulations often requires putting an implicit price tag on lives, but there is little agreement on the right way to do it. Should all regulations use the same value of a statistical life, or should it vary based on a person's...

This two-volume collection of key papers by leading scholars provides a comprehensive perspective on the evaluation and performance of risk regulation policies.

In 1980, the Environmental Protection Agency launched its Superfund program. Although modified in 1986, the Superfund effort is a major target of congressional reform efforts. Policymakers and analysts have two main sources of dissatisfaction. First, cleanups of hazardous wastes are expensive, averaging $25.7 million per site. Estimates of the...

This monograph assesses how the adverse health implications associated with regulatory costs can affect mortality risk by considering a broad group of federal regulations.

This volume examines state regulations for hazard warnings--for foods, drugs, and medical devices--and demonstrates why a federal warnings approach would be preferable.

But the mere existence of income inequality tells us little about what, if anything, should be done about it.

Would the war in Iraq pass a cost-benefit test?